LRP2 and type 2 diabetes mellitus: A large European population study found no association between some LRP2 polymorphism and eGFR decline [22], while a study of African Americans revealed a novel missense LRP2 mutation that protected from type 2-diabetes mellitus-associated end-stage kidney disease [23].